Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone app boost CPAP therapy for sleep apnea?

NCT ID NCT05049928

Disease control Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding a telerehabilitation program (using a mobile app, video calls, and online coaching) to standard CPAP therapy helps obese adults with severe sleep apnea. 180 participants were followed for 6 months to see if the program improved daytime sleepiness, quality of life, blood pressure, and inflammation. The goal is to see if technology can help people make lasting lifestyle changes alongside their breathing machine.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
telerehabilitation program (mobile app, teleconsultation, video conferencing with health professionals)
What this could lead to
If it works, this could show that adding a home-based rehab program to standard CPAP therapy helps people with sleep apnea feel less sleepy and have better heart health.
What could go wrong
This is a completed study, but results are not yet widely confirmed. The program requires patient motivation and access to technology, which may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

180 people

The number who actually took part.

Started

Sep 2021

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Severe obstructive sleep apnea (apnea-hypopnea index ≥30 / hour) * Body mass index ≥ 30 kg / m² * age between 30 and 75 years old * written consent Exclusion Criteria: * Presence of contraindications to perform exercise training (neuromuscular disease, orthopedic cause, acute coronary syndrome or stroke in the previous three months) * Active infection, chronic inflammatory disease, cancer under treatment. Systemic treatment with immunosuppressants or corticosteroids * Obstructive Sleep Apnea treated by Continuous Positive Airway Pressure or mandibular advancement device in the 3 months preceding inclusion * Participation in a rehabilitation program scheduled within six months of inclusion * Predominantly central sleep apnea syndrome (AC\> 50%) * Heart failure with Left Ventricular Ejection Fraction \<40% known * Bariatric surgery in the previous 6 months or bariatric surgery project in the 6 months * Alcohol\> 14 drinks per week * Inability to understand and / or answer questionnaires. * Refusal to use a smartphone or digital device * Inability to access an internet connection at home. * Subject in a period of relative exclusion with respect to another protocol or for which the maximum annual amount of compensation of € 4,500 has been reached. * Subject not affiliated with a social security scheme, or not beneficiary of such a scheme. * Pregnant or breastfeeding woman, patient unable to give her protected adult consent, vulnerable people * Subject deprived of liberty by judicial or administrative decision

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obstructive sleep apnea syndrome are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obstructive sleep apnea syndrome

Contacts and locations

Locations

  • CHU Montpellier

    Montpellier, 34080, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.